Abstract
Heart Diseases are a major cause of morbidity and mortality world wide. Myocardial infarction is the leading cause of congestive heart failure and death in the industrialized world. Current therapy is limited in preventing the progression of ventricular remodeling and congestive heart failure. Recent interest has focused on stem cells, which are undifferentiated and pleuropotent cells that can proliferate, potentially self-renew, and differentiate into cardiomyocytes. The article tries to underline the beneficial effects of the stem cell therapy for use in patients where other modes of therapy are not advisable and the multi purpose effects of such as therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have